| Page 20 | Cafepharma

You are here

Primary tabs

GSK's Trelegy Ellipta Gains New Indication in the US for the Treatment of Patients With COPD

Post date: April 24, 2018 - 2:26pm

Celgene's Ozanimod Reduces Relapses and Brain Volume Loss in MS Patients in Phase III Trials

Post date: April 24, 2018 - 9:25am

Tarveda Therapeutics Doses First Patient in Study of Innovative Conjugate PEN-866 for Patients With Solid Tumors

Post date: April 24, 2018 - 9:02am

Surface Oncology Banks $119.5 Million With IPO and Private Placement

Post date: April 23, 2018 - 8:20pm

Lemtrada Treatment Effects in MS Patients Maintained Over Seven Years

Post date: April 23, 2018 - 7:56pm

Nuprobe Closes $11 Million Series A Round to Develop Molecular Diagnostics

Post date: April 23, 2018 - 4:41pm

GENFIT Receives Positive Safety Review for NASH Candidate Elafibranor

Post date: April 23, 2018 - 10:00am

EU Advisory Group Backs Orphan Drug Designation for Alnylam's ALN-TTRsc02 for ATTR Amyloidosis

Post date: April 23, 2018 - 9:36am

FDA Fails to Approve Pfizer's Biosimilar of Roche's Herceptin

Post date: April 23, 2018 - 9:20am

FDA Grants Breakthrough Therapy Status to Pfizer's Trumenba for Prevention of Meningococcal B Disease in Children

Post date: April 23, 2018 - 9:03am

Pages